跳至主要内容
临床试验/CTRI/2023/03/051059
CTRI/2023/03/051059尚未招募Unknown

A Comparative Pharmacaceutico -Clinical study of Navak guggulu made by two different shodhana media on medoroga w.s.r to obesity

Goverment Ayurvedic College, Patna0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients willing for the trial & able to participate for 3 months after consent.
  • A) Patients suffering from Medoroga
  • B) Patients suffering from Hyperlipidemia (Particularly high cholesterol & LDL)
  • or both will take part of this criteria.
  • Total cholesterol (mg/dl) - >200, LDL (mg/dl)- >130, VLDL (mg/dl)- >35, Triglycerides- >150 mg/dl
  • Patientâ??s age between 25-80 years

排除标准

  • Medoroga due to endocrinal disorder like Hypothyroidism, Cushing syndrome etc.
  • Drug induced obesity and Hyperlipidemia such as long-term intake of OCP, Beta Blockers & Corticosteroids
  • Age below 25 and above 80 years.
  • Patients having complications like Renal Disease, Diabetes, Hypertension, Mental Disorder etc.
  • Patients having any other systemic illness. Like genetical disorder etc
  • Pregnancy & Breast Feeding

研究者

发起方
Goverment Ayurvedic College, Patna

相似试验